APPLICATIONS PUBLISHED 25 JUNE 2005

Hematopoietic stem cells and methods of treatment of neovascular eye diseases
The Scripps Research Institute 1542536*

Lipase inhibitors and uses thereof
Danisco 1542538*

Antibiotic product, use and formulation thereof
Advancis Pharmaceutical 1542656*

Cannabinoid liquid formulations for mucosal administration
GW Pharma 1542657*

Pharmaceutical compsns
Euro-Celtique 1542658*

Process for coating a pharmaceutical particle
EI du Pont de Nemours 1542659*

Sustained release delivery of amphetamine salts
Shire Laboratories 1542660*

Modified release dosage form with two cores
McNeil-PPC 1542661*

Immediate release dosage form comprising shell having openings therein
McNeil-PPC 1542662*

A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
Zhang, Jin Jun 1542663*

Methods and compsns for treatment of macular and retinal disease
Medical College of Georgia Research Institute 1542664*

Method for treating depression and/or anxiety
Merck 1542665*

Modafinil pharmaceutical compsns
Cephalon 1542666*

Ureido substituted benzoic acid compounds and their use for non-sense suppression and the treatment of disease
PTC Therapeutics 1542667*

Aripiprazole complex formulation and method
Bristol-Myers Squibb 1542668*

Leucine-enriched nutritional compsns
Novartis 1542669*

Compsn containing arachidonic acid alone or in combination with docosahexaenoic acid for enhancing cognitive abilities
Suntory 1542670*

Compsn based on triethyl citrate for the treatment of bacterial infections of the skin
De Paoli Ambrosi, Gianfranco 1542671*

R-bambuterol, its preparation and therapeutic uses
Cheng, J. L. 1542672*

Use of (r)-verapamil for the treatment of abnormal increases in gastrointestinal motility
Agi Therapeutics 1542673*

Chondropsin-class antitumour V-atpase inhibitor compounds, compsns and methods of use thereof
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1542674*

Compnsn useful for the inhibition of ALDH
The Endowment for Research in Human Biology 1542675*

Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2"-hydroxyflavonoids
Pharmacogenetics 1542676*

Combinations of atorvastatin and A1, adrenergic receptor antagonists
Pfizer 1542677*

1H-1,2,4-triazole-3-caroxamide derivatives cannabinoid-CB receptor ligands
Solvay Pharmaceuticals 1542678*

4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of I. A. HIV
Pfizer 1542679*

1,4,5-substituted 1,2-dihydro-pyrazol-3-one and 3-alkoxy-1H-pyrazole derivatives S TNF-alpha and interleukin lowering agents for the treatment of inflammations
Amgen 1542680*

Use of posaconazole for the treatment of fungal infections
Schering 1542681*

Novel inhibitors of ubiquitin isopeptidases
University of Utah Research Foundations 1542682*

Calcium channel blockers
Diakron Pharmaceuticals 1542683*

Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
Pfizer 1542684*

Triazole derivatives as transforming growth factor (TGF) inhibitors
Pfizer 1542685*

Aryl substituted hydantoin compounds and their use as sodium channel blockers
Euro-Celtique 1542686*

Small organic molecules that increase the activity of gelatinase A in ocular cells
Bausch & Lomb 1542687*

1H-imidazo dimers
3M Innovative Products 1542688*

Improved process for hydroxyazapirones
Bristol-Myers Squibb 1542689*

Manzamine-producing actinomycetes
University of Maryland Biotechnology Institute 1542690*

Compsn for the treatment of nasopharyngeal carcinoma and use thereof
Societe de Conseils de Recherches et d"Applications Scientifiques; Centre National de la Recherche Scientifique 1542691*